Pharmaceutical Technology's In the Lab eNewsletter
The risks of microbial contamination inherent in the production of viral vaccines and viral vectors used in biotherapeutic applications must be addressed.
Priyabrata Pattnaik
Advertisement
Priyabrata Pattnaik, PHD, is head of biologics operations-Asia Pacific, MilliporeSigma.
Articles by Priyabrata Pattnaik
Advertisement
Latest Updated Articles
Preventing Microbial Contamination of Viral Vaccines and VectorsOctober 3rd 2018
Advertisement
Advertisement